Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy.
Loading...
Authors
Contact
Check for full-text access
Issue Date
Type
Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Publisher
License
Journal
European heart journal